Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 29 | 2025 | 691 | 3.600 |
Why?
|
| Diabetes Mellitus | 7 | 2024 | 390 | 2.020 |
Why?
|
| Hypertension | 10 | 2024 | 979 | 1.770 |
Why?
|
| Low Back Pain | 7 | 2022 | 43 | 1.180 |
Why?
|
| United States | 34 | 2025 | 4072 | 1.160 |
Why?
|
| Medicare | 3 | 2025 | 219 | 1.110 |
Why?
|
| Automobile Driving | 5 | 2023 | 25 | 1.100 |
Why?
|
| Humans | 89 | 2025 | 32284 | 1.080 |
Why?
|
| Rural Population | 3 | 2024 | 216 | 1.030 |
Why?
|
| Risk Factors | 26 | 2025 | 3934 | 0.970 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 204 | 0.910 |
Why?
|
| Female | 58 | 2025 | 19947 | 0.900 |
Why?
|
| Models, Statistical | 3 | 2023 | 187 | 0.890 |
Why?
|
| Body Mass Index | 5 | 2025 | 863 | 0.840 |
Why?
|
| Ambulatory Care | 1 | 2025 | 112 | 0.840 |
Why?
|
| Aged | 32 | 2025 | 10265 | 0.830 |
Why?
|
| Male | 48 | 2025 | 19443 | 0.810 |
Why?
|
| Urban Population | 1 | 2024 | 91 | 0.800 |
Why?
|
| Licensure | 4 | 2023 | 7 | 0.800 |
Why?
|
| Health Status Disparities | 6 | 2023 | 128 | 0.780 |
Why?
|
| Obesity | 3 | 2025 | 1111 | 0.700 |
Why?
|
| Middle Aged | 32 | 2025 | 11853 | 0.640 |
Why?
|
| Adult | 32 | 2025 | 9259 | 0.630 |
Why?
|
| Cohort Studies | 14 | 2025 | 1840 | 0.580 |
Why?
|
| Incidence | 14 | 2024 | 1241 | 0.570 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 122 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 1437 | 0.530 |
Why?
|
| Social Class | 7 | 2023 | 90 | 0.510 |
Why?
|
| Longitudinal Studies | 14 | 2025 | 757 | 0.510 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 140 | 0.480 |
Why?
|
| Dental Hygienists | 1 | 2014 | 1 | 0.440 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 5 | 0.430 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 227 | 0.430 |
Why?
|
| Poisson Distribution | 3 | 2023 | 17 | 0.430 |
Why?
|
| Unsafe Sex | 1 | 2014 | 23 | 0.430 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 242 | 0.410 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 1158 | 0.400 |
Why?
|
| Public Health | 1 | 2014 | 91 | 0.400 |
Why?
|
| Aged, 80 and over | 8 | 2025 | 3902 | 0.400 |
Why?
|
| Caregivers | 2 | 2025 | 114 | 0.390 |
Why?
|
| Students | 1 | 2014 | 174 | 0.390 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 183 | 0.390 |
Why?
|
| Computer Simulation | 5 | 2023 | 251 | 0.390 |
Why?
|
| Protein Precursors | 2 | 2024 | 24 | 0.380 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 1479 | 0.360 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 252 | 0.330 |
Why?
|
| Child Restraint Systems | 2 | 2021 | 3 | 0.330 |
Why?
|
| Coronary Disease | 3 | 2022 | 226 | 0.320 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 293 | 0.310 |
Why?
|
| Dental Caries | 3 | 2019 | 21 | 0.310 |
Why?
|
| Prevalence | 5 | 2024 | 955 | 0.310 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 363 | 0.290 |
Why?
|
| HIV Infections | 1 | 2014 | 450 | 0.290 |
Why?
|
| Exercise | 5 | 2024 | 603 | 0.280 |
Why?
|
| Fertility | 3 | 2013 | 24 | 0.280 |
Why?
|
| Residence Characteristics | 4 | 2022 | 178 | 0.280 |
Why?
|
| DMF Index | 3 | 2019 | 6 | 0.280 |
Why?
|
| Leisure Activities | 2 | 2024 | 16 | 0.270 |
Why?
|
| Prospective Studies | 9 | 2024 | 2316 | 0.250 |
Why?
|
| Child | 10 | 2024 | 2435 | 0.240 |
Why?
|
| Socioeconomic Factors | 6 | 2023 | 388 | 0.240 |
Why?
|
| Comorbidity | 2 | 2025 | 565 | 0.230 |
Why?
|
| Cognition | 3 | 2024 | 547 | 0.230 |
Why?
|
| Enkephalins | 2 | 2024 | 11 | 0.230 |
Why?
|
| Diet | 6 | 2023 | 383 | 0.220 |
Why?
|
| Regression Analysis | 2 | 2016 | 273 | 0.220 |
Why?
|
| Work Schedule Tolerance | 1 | 2024 | 7 | 0.220 |
Why?
|
| Mental Health | 2 | 2023 | 111 | 0.220 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 46 | 0.220 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 853 | 0.210 |
Why?
|
| Leptin | 1 | 2024 | 61 | 0.210 |
Why?
|
| Depression | 3 | 2025 | 420 | 0.210 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2024 | 28 | 0.200 |
Why?
|
| Patient Discharge | 1 | 2025 | 204 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2024 | 56 | 0.200 |
Why?
|
| Cognition Disorders | 2 | 2024 | 349 | 0.200 |
Why?
|
| Independent Living | 1 | 2024 | 90 | 0.200 |
Why?
|
| Survivors | 1 | 2025 | 173 | 0.200 |
Why?
|
| Ovulation Detection | 2 | 2013 | 2 | 0.200 |
Why?
|
| Sleep | 2 | 2021 | 84 | 0.190 |
Why?
|
| Pregnancy | 8 | 2021 | 961 | 0.190 |
Why?
|
| Health Behavior | 2 | 2021 | 211 | 0.190 |
Why?
|
| Blood Glucose | 2 | 2025 | 484 | 0.190 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 245 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 186 | 0.190 |
Why?
|
| Motor Activity | 1 | 2024 | 332 | 0.190 |
Why?
|
| Neuropeptides | 1 | 2022 | 23 | 0.180 |
Why?
|
| Air Pollution | 1 | 2021 | 15 | 0.180 |
Why?
|
| Peptide Fragments | 2 | 2022 | 415 | 0.180 |
Why?
|
| Air Pollutants | 1 | 2021 | 26 | 0.180 |
Why?
|
| Quality of Life | 2 | 2025 | 964 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3628 | 0.170 |
Why?
|
| Adolescent | 6 | 2023 | 3519 | 0.170 |
Why?
|
| Sex Factors | 5 | 2021 | 657 | 0.170 |
Why?
|
| Firearms | 1 | 2021 | 8 | 0.170 |
Why?
|
| Seat Belts | 1 | 2021 | 18 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 86 | 0.170 |
Why?
|
| Geography | 4 | 2021 | 30 | 0.170 |
Why?
|
| Aggression | 1 | 2020 | 27 | 0.160 |
Why?
|
| Soccer | 1 | 2020 | 18 | 0.160 |
Why?
|
| Sports | 1 | 2021 | 43 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 37 | 0.160 |
Why?
|
| Risk Assessment | 6 | 2024 | 1425 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2020 | 173 | 0.150 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 109 | 0.150 |
Why?
|
| Young Adult | 5 | 2024 | 2649 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2019 | 90 | 0.150 |
Why?
|
| Selection Bias | 1 | 2019 | 13 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2020 | 83 | 0.150 |
Why?
|
| Algorithms | 1 | 2022 | 536 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2019 | 60 | 0.140 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 181 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2023 | 854 | 0.140 |
Why?
|
| Pain Measurement | 4 | 2022 | 341 | 0.140 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 9 | 0.130 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 170 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2019 | 456 | 0.130 |
Why?
|
| Narcotics | 1 | 2017 | 32 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 126 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 10 | 0.130 |
Why?
|
| Heart Failure | 1 | 2024 | 728 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 117 | 0.130 |
Why?
|
| Cocaine | 2 | 2017 | 354 | 0.130 |
Why?
|
| Bicycling | 1 | 2016 | 12 | 0.120 |
Why?
|
| Time Factors | 5 | 2024 | 2205 | 0.120 |
Why?
|
| Placenta Previa | 1 | 2016 | 2 | 0.120 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 13 | 0.120 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2016 | 1 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 12 | 0.120 |
Why?
|
| Binomial Distribution | 1 | 2015 | 2 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 53 | 0.120 |
Why?
|
| Accidents | 1 | 2015 | 5 | 0.110 |
Why?
|
| Benzodiazepines | 1 | 2015 | 10 | 0.110 |
Why?
|
| Premature Birth | 1 | 2016 | 73 | 0.110 |
Why?
|
| Dentin | 1 | 2014 | 1 | 0.110 |
Why?
|
| Calcium Hydroxide | 1 | 2014 | 2 | 0.110 |
Why?
|
| Silicates | 1 | 2014 | 3 | 0.110 |
Why?
|
| Aluminum Compounds | 1 | 2014 | 4 | 0.110 |
Why?
|
| Dental Care for Aged | 1 | 2014 | 4 | 0.110 |
Why?
|
| Root Canal Filling Materials | 1 | 2014 | 3 | 0.110 |
Why?
|
| Calcium Compounds | 1 | 2014 | 9 | 0.110 |
Why?
|
| Stereotyping | 1 | 2014 | 10 | 0.110 |
Why?
|
| Homes for the Aged | 1 | 2014 | 13 | 0.110 |
Why?
|
| Lead | 1 | 2014 | 4 | 0.110 |
Why?
|
| Oxides | 1 | 2014 | 17 | 0.110 |
Why?
|
| Harm Reduction | 1 | 2014 | 15 | 0.110 |
Why?
|
| Nursing Homes | 1 | 2014 | 33 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2014 | 50 | 0.110 |
Why?
|
| Inflammation | 3 | 2022 | 506 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 68 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 757 | 0.100 |
Why?
|
| Cervix Mucus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Parents | 3 | 2023 | 151 | 0.100 |
Why?
|
| West Virginia | 3 | 2020 | 16 | 0.100 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2012 | 1 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 97 | 0.090 |
Why?
|
| Lubricants | 1 | 2012 | 2 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 773 | 0.090 |
Why?
|
| Age Factors | 3 | 2020 | 1179 | 0.090 |
Why?
|
| Albuminuria | 2 | 2024 | 172 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2025 | 217 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 408 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 327 | 0.090 |
Why?
|
| Vagina | 1 | 2012 | 61 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 23 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Neoplasms | 1 | 2019 | 754 | 0.090 |
Why?
|
| Molar, Third | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tooth Extraction | 1 | 2011 | 18 | 0.090 |
Why?
|
| Minocycline | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cryotherapy | 1 | 2011 | 12 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2021 | 1233 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 62 | 0.080 |
Why?
|
| Alabama | 2 | 2021 | 41 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 316 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2017 | 666 | 0.080 |
Why?
|
| Vitamin D | 1 | 2011 | 186 | 0.080 |
Why?
|
| Research Design | 2 | 2025 | 314 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 199 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 324 | 0.070 |
Why?
|
| Forensic Toxicology | 2 | 2020 | 3 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2024 | 861 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 541 | 0.060 |
Why?
|
| Logistic Models | 2 | 2021 | 743 | 0.060 |
Why?
|
| Educational Status | 2 | 2018 | 167 | 0.060 |
Why?
|
| Dental Caries Susceptibility | 2 | 2017 | 2 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 883 | 0.060 |
Why?
|
| Infant | 2 | 2019 | 1010 | 0.060 |
Why?
|
| Freezing | 1 | 2025 | 6 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2025 | 73 | 0.050 |
Why?
|
| Glasgow Outcome Scale | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2025 | 52 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 53 | 0.050 |
Why?
|
| Health Surveys | 1 | 2024 | 175 | 0.050 |
Why?
|
| Executive Function | 1 | 2024 | 52 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2025 | 75 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2025 | 124 | 0.050 |
Why?
|
| Snoring | 1 | 2024 | 9 | 0.050 |
Why?
|
| Transportation | 1 | 2023 | 10 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 133 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2023 | 6 | 0.050 |
Why?
|
| Social Environment | 1 | 2023 | 74 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2023 | 49 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 10 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 224 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 84 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2022 | 24 | 0.050 |
Why?
|
| Censuses | 1 | 2022 | 10 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 2 | 0.050 |
Why?
|
| Neurotensin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 8 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2240 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 82 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 132 | 0.040 |
Why?
|
| Cities | 1 | 2021 | 7 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 302 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 160 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2021 | 32 | 0.040 |
Why?
|
| Food Supply | 1 | 2022 | 64 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 9 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 109 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2021 | 60 | 0.040 |
Why?
|
| Income | 1 | 2021 | 66 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2021 | 93 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2022 | 144 | 0.040 |
Why?
|
| Child Behavior | 1 | 2021 | 25 | 0.040 |
Why?
|
| Movement | 1 | 2021 | 61 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 97 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 308 | 0.040 |
Why?
|
| Coroners and Medical Examiners | 1 | 2020 | 6 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 393 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 94 | 0.040 |
Why?
|
| Video Recording | 1 | 2020 | 61 | 0.040 |
Why?
|
| Parenting | 1 | 2020 | 23 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2020 | 50 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 543 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 174 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 194 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 242 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 82 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 444 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 425 | 0.040 |
Why?
|
| Physicians, Family | 1 | 2019 | 14 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2018 | 12 | 0.040 |
Why?
|
| Japan | 1 | 2018 | 19 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 253 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 91 | 0.040 |
Why?
|
| American Heart Association | 1 | 2019 | 92 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 131 | 0.030 |
Why?
|
| Meconium | 1 | 2017 | 2 | 0.030 |
Why?
|
| Cause of Death | 1 | 2019 | 236 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 7 | 0.030 |
Why?
|
| Opiate Alkaloids | 1 | 2017 | 2 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 18 | 0.030 |
Why?
|
| Cardiology | 1 | 2019 | 104 | 0.030 |
Why?
|
| Dentifrices | 1 | 2017 | 1 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 90 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 247 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 122 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 556 | 0.030 |
Why?
|
| Hallucinogens | 1 | 2016 | 13 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 395 | 0.030 |
Why?
|
| Mouthwashes | 1 | 2015 | 3 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 255 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 125 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 942 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 84 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 287 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 8 | 0.030 |
Why?
|
| Tooth, Deciduous | 1 | 2014 | 3 | 0.030 |
Why?
|
| Particle Size | 1 | 2014 | 48 | 0.030 |
Why?
|
| Rheology | 1 | 2014 | 35 | 0.030 |
Why?
|
| Dental Care | 1 | 2014 | 16 | 0.030 |
Why?
|
| Urban Health | 1 | 2014 | 14 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 102 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 321 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 101 | 0.030 |
Why?
|
| Birth Weight | 1 | 2014 | 46 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 89 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2014 | 52 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2014 | 47 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 38 | 0.030 |
Why?
|
| Poverty | 1 | 2014 | 105 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 368 | 0.030 |
Why?
|
| Fertilization | 1 | 2013 | 5 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 144 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2014 | 138 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 232 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2019 | 820 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 77 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2012 | 9 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 6 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 191 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 169 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 39 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2011 | 90 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 651 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 113 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2011 | 142 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 55 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 111 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 555 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 1300 | 0.020 |
Why?
|